Ashwa
Food supplement declared in France, decision dated 5 November 2026
Ashwa (Elixir Alchimique) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.
- Brand
- Elixir Alchimique
- Food business operator placing the product on the market
- VITURET Florent
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 81 gouttes (1,62 ml), soit 630 mg de plante fraîche.
- Directions for use
- 3 à 9 gouttes sous la langue, selon le besoin et le ressenti, jusqu’à 9 fois par jour. Ne pas dépasser 81 gouttes par jour. Agiter avant utilisation.
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Pregnant women, Taking antidepressants, Taking medication, Taking thyroid medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Sexual vitality, Concentration, Immunity, Memory, Sleep, Nervous system, Joints
Declaration 380951, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Withania somnifera (L.) Dunal | Racine | Alcoolature | 1.62 ml |
Other active ingredients
| Name | Per day |
|---|---|
| miel | not declared |
Other ingredients
Alcool, eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé aux femmes enceintes, allaitantes, aux personnes de moins de 18 ans ou atteintes de troubles endocriniens (dysthyroïdies et l’hyperandrogénie) et/ou de troubles hépatiques ou cardiaques. Déconseillé en cas de conduite de véhicules ou l’utilisation de machines et/ou en association avec des substances à action dépressive du système nerveux central.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- ASHWA+ Drdaxiong, declared in 2026 : different composition: 1 ingredient(s) added, 4 missing
- ASHWA+ Drdaxiong, declared in 2026 : different composition: 1 ingredient(s) added, 4 missing
- ASHWA+ Drdaxiong, declared in 2026 : different composition: 1 ingredient(s) added, 4 missing
- ASHWA+ Drdaxiong, declared in 2026 : different composition: 1 ingredient(s) added, 4 missing
- Ashwa+ BiotechUSA, declared in 2023 : different composition: 11 ingredient(s) added, 3 missing
Brand : Elixir Alchimique
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.